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Bone morphogenetic protein-7 (BMP)-7 plays an important
role during fetal kidney development. In the adult, BMP-7 is
most strongly expressed in the kidney compared to other
organs, but the exact expression pattern as well as the
function of BMP-7 is unclear. The major aim of the present
study was to define which parts of the human kidney do
physiologically express BMP-7 and which cells appear to be
targets of BMP activity by showing phosphorylated
BMP-receptor-associated Smads 1, 5, or 8 and inhibitor of
differentiation factor 1 (ID1) expression. BMP-7 expression
was localized by immunohistology to the epithelia of the
distal tubule as well as the collecting ducts (CDs).
Phospho-Smads 1/5/8 and ID1 expression largely colocalized
with BMP-7 and was also localized in the epithelia of the
distal tubule and the CDs. This was confirmed by polymerase
chain reaction-based mRNA expression analysis. In vitro,
proximal tubular cells (PTCs) expressed BMP receptors and
BMP-receptor-associated Smads and were reactive to BMP-7.
Our data indicate that BMP-7 expression in the adult human
kidney appears to be more restricted than in the fetal
situation and predominantly found in the distal nephron.
Also, evidence of in vivo BMP signalling (i.e. phospho-Smads
and ID1 expression) was found there. These findings suggest
that BMP-7 plays a physiological role mostly in this part of
the kidney. Still, as reported previously, PTCs are responsive
to BMP-7, but presumably not in an autocrine or paracrine
mode in normal adult kidneys.
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Bone morphogenetic protein (BMP)-7 represents one
member of the BMP/transforming growth factor-b-super-
family, which is thought to play important roles during
development, but also in adult physiology and disease. BMP-
7 itself seems to play specifically an important role during
fetal kidney development and is expressed multifocally within
the embryonic metanephric mesenchyme and epithelia (for a
review see Simic and Vukicevic1). BMP-7 knockout mice die
owing to renal failure perinatally as a result of severe kidney
dysplasia. Thus, overall, BMP-7 is one of the most potent
renal morphogenic factors during kidney development.
In the adult, BMP-7 is most strongly expressed in the
kidney at least in mice.2 The exact expression pattern as well
as the function of BMP-7 are unclear in the adult. How-
ever, BMP-7 was repeatedly reported to be protective in
acute and chronic kidney disease (for a review see Simic and
Vukicevic1): Thus, BMP-7 improved significantly the reco-
very rate after acute renal injury in terms of histomorphology
as well as function.3 Also, chronic injuries including diabetic
nephropathy are counteracted.4 Although the exact molecu-
lar mechanisms are still unknown, BMP-7 appears to reduce
the release of proinflammatory cytokines,5 may be via
direct mitogen-activated protein kinase signaling,6 and is
able to reverse epithelial–mesenchymal transitions as well as
to counteract the fibrotic activity of transforming growth
factor-b.7,8 Altogether, BMP-7 appears to help to restore the
tubular homeostasis in a surprisingly efficient way.1
BMP activity in general is on the cellular level mediated
via binding of BMP to BMP-specific receptors IA, IB, and II
on the cell surface (for a review see Sebald et al.9 and Chen
et al. 10). Activated receptor complexes recruit and phos-
phorylate BMP-receptor-associated Smads 1, 5, and 8, which
than bind to common-Smad 4. The Smad complexes then
translocate into the nucleus where they act in concert with
other factors as transcription factors. Among others, the
inhibitory Smads 6/7 and the inhibitor of differentiation
family member 1 (ID1) are known as positively regulated
gene targets of BMP activity.
The aim of the present study was to define which parts of
the human kidney do physiologically express BMP-7 and
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which cells appear to be targets of BMP activity by showing
phosphorylated BMP-receptor-associated Smads 1, 5, or 8
and ID1 expression in situ in adult human kidney tissue.
RESULTS
Gene expression analysis of BMP-7 in normal adult human
kidney using conventional and quantitative PCR
By conventional polymerase chain reaction (PCR), tran-
scripts for BMP-7 mRNA could be detected in all RNAs
isolated from normal adult kidney (Figure 1a). Quantitative
PCR confirmed these results and showed low expression
levels of BMP-7 in total kidney RNA extracts (Figure 1b).
These were, however, higher than those detectable in other
organs (Figure 1b).
In situ localization of BMP-7 in the adult kidney – mRNA
expression analysis of microdissected glomeruli and tubuli
Immunostaining localized BMP-7 expression to the
epithelia of the distal tubule (Figure 2a and c). This specific
distribution pattern was confirmed by double-labelling
experiments with calbindinD28k for the identification of
the distal convolute and collecting ducts (CDs) (Figure 2b,
and d). This showed a large number of double-positive
tubuli, distal-convoluted tubule (DCT), and connective
tubule (CNT) as well as few of only calbindinD28k (CD)
or only BMP-7-stained tubuli. No expression was detected in
the proximal tubuli and the glomeruli. Of interest, the most
prominent immunostaining was found in the cytoplasm at
the luminal side of tubular epithelial cells.
Quantitative PCR was performed on microdissected
human glomeruli and tubules: significant BMP-7 expression
was mostly detectable in dissected tubular cells and hardly
detected in glomeruli (o0.01 molecules/molecules glyceral-
dehyde-3-phosphate dehydrogenase).
Proximal tubular epithelia lack endogenous BMP-7,
but do respond to rhBMP-7 in vitro
According to our immunostainings, BMP-7 is not expressed
in proximal tubular cells (PTCs) and glomeruli (Figure 2a
and c). Also, an established cell line of PTCs, HK-2,11 did not
express BMP-7 even if investigated with highly sensitive PCR.
However, this cell line expressed significant levels of BMP
receptors IA, IB, and II as well as BMP activity mediating
R-Smads 1, 5, and 8 (Figure 3a). Stimulation of HK-2 cells
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Figure 1 | mRNA expression of BMP-7 in normal adult kidney.
(a) Detection of a BMP-7 amplification product (500 bp) in four
different kidney samples by conventional PCR (lane 1: DNA marker,
lane 2: H20 control; lanes 3–6: four different kidney specimens).
(b) Real-time PCR analysis of the BMP-7 expression level
demonstrates a BMP-7 activity in four separate samples of human
adult kidney and to a much lower extent in other organ samples.
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Figure 2 | Immunolocalization of BMP-7 in normal adult kidney.
(a, c) Immunostaining for BMP-7. (a) original magnification 20
(bar¼ 100 mm); (c) original magnification 40 (bar¼ 50mm): no
signal was detected in glomeruli and proximal tubuli (*). (b, d)
Double immunofluorescence showing the relation between BMP-7
(green) and calbindinD28k (red) (b) original magnification 10
(bar¼ 200 mm); (d) original magnification 20 (bar¼ 100 mm): there
is only a small population of double-stained distal tubuli.
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Figure 3 | Quantification of BMP receptor and Smad 6/7 mRNA
expression in HK2 cells. (a) Quantitative mRNA expression analysis
of BMP receptors as well as BMP-7 in HK-2 in primary PTCs.
(b) Detection of statistically significant Smads 6 and 7 upregulation
after stimulation with BMP-7 (100 ng/ml for 16 h) by real-time PCR.
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with 100 ng/ml BMP-7 lead to an increased expression of
Smads 6 and 7 (Figure 3), which are known to be upregulated
by BMPs in a negative feedback manner. Similar results were
obtained with primary PTCs (Figure 3b).
Immunolocalization of P-Smads 1, 5, and 8 and ID1 in normal
adult kidney – co-immunolocalization with BMP-7
We were then interested in looking for BMP-receptor-
associated Smad activation in the normal kidney. Phospho-
smads (p-Smads) 1/5/8 and ID1 were detected in the
epithelia of the distal tubuli (DCT, CNT) and the CD, based
upon the morphological characteristics of the stained tubuli.
Co-labelling with Tamm–Horsfall protein as a marker for the
thick ascending limb showed a majority of positive p-Smads
tubuli and just some tubuli either positive for Tamm–Horsfall
protein alone or simultaneously for both. This indicates that
the p-Smad-labelled tubuli must be located at the transition
of thick ascending limb/DCT to the CNT and CD (Figure 4b
and e).
To confirm our p-Smad data, we investigated the ID1
distribution as effector downstream of the p-Smads 1/5/8
signaling. Supporting our former findings, the ID1 stainings
showed a pattern similar to that of the p-Smads 1/5/8
(Figure 5).
BMP-7 showed an apical distribution and was localized to
the distal tubuli, mostly in close colocalization with p-Smads
(see Figure 4c and f, green staining). Other tubuli were either
only BMP-7 (i.e. DCT, CNT) or p-Smads 1/5/8 and ID1
positive. BMP-7 was also colocalized with ID1 in DCT and
CNT (Figure 5c and f, green staining). Neither p-Smads, ID1,
nor BMP-7 was seen in glomeruli.
DISCUSSION
BMP-7, a well-known important morphogenetic factor
during nephrogenesis, is also expressed and active in the
adult human kidney. Interestingly, our data indicate that
BMP-7 expression in the adult kidney is much more restric-
ted than in the fetal situation and predominantly found in
the distal nephron. This is in line with previous studies in
mice and rat documenting the kidney as a major site of BMP-
7 expression,2 with the most prominent staining seen in the
distal tubulus and the CDs.5,12–14 Other reported localizations
include glomerular cells and renal arteries13 or weak staining
in some PTCs.14 These findings, however, appear to be
different in between the species. According to our data in
human kidneys, BMP-7 is hardly found in these cells and was
not detectable by our antibody staining.
BMP-7 activity is mediated by BMP receptors and
phosphorylation of R-Smads 1, 5, and 8. Interestingly, phos-
phorylation of the latter was also specifically found in our
study in the distal nephron and the CDs basically overlapping
with the BMP-7 expression. This, together with the restricted
expression of BMP-7 suggests that BMP-7 plays a physio-
logical role mostly in these kidney areas. Also, the mostly
luminal distribution of the immunostaining of BMP-7
suggests urinary excretion of BMP-7, further supporting that
physiological activity of BMP-7 is largely restricted to distal
nephron areas. Interestingly, BMP-7 knockout mice show
adequate glomerulogenesis, but poor nephron development:
whereas the proximal convoluted tubule appears to be well
formed, the DCT is largely deficient.15
Despite the absence of detectable BMP-7 expression in
glomeruli and PTCs as well as the absence of sufficiently high
levels of BMP-7 in the circulating blood to stimulate cells, all
epithelia in the kidney have BMP receptors at least in adult
mice16 and rats5 and appear to be responsive to BMP
activity.5,11,12 In line with these previous studies, also our
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Figure 4 | Immunolocalization of phosphor-Smads 1/5/8 in
normal adult kidney. (a, d) Immunolocalization of phospho-Smads
1/5/8 (p-Smad) a: original magnification 10 (bar¼ 200 mm),
d: original magnification 20 (bar¼ 100mm) in normal adult kidney:
positive staining for p-Smad was observed in distal tubular structures,
whereas glomeruli and the proximal tubuli remained unstained.
(b) Double immunofluorescence for p-Smads 1/5/8 (red) and
Tamm–Horsfall–protein (THP; green): original magnification 8
(bar¼ 200 mm); e: original magnification 40 (bar¼ 50 mm): only a
small number of double-positive tubuli was observed. (c, f) Double
immunofluorescence for p-Smads 1/5/8 (red) and BMP-7 (green)
c: original magnification 10 (bar¼ 100mm); f: original
magnification 40 (bar¼ 50mm, nuclear staining: 40,6-diamino-2-
phenylindole-2HCl): a higher number of double-positive tubuli
besides tubuli positive only for p-Smads 1/5/8.
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study shows that immortalized well-differentiated PTCs
(HK-2) express the BMP receptors, the BMP-signalling
Smads, and are responsive to BMP-7. Thus, Smad 6 and 7,
which are known to be responsive to BMP stimulation in
many cells,17–22 and the ID-1 gene (own unpublished data)
were upregulated. A very intriguing speculation is that
under adverse (e.g. hypoxic) conditions BMP-7 can act as a
physiological protector of the distal tubule,5 whereas the
proximal tubule is prone to ischemic injury. This hypothesis
is supported in many facets by our data as discussed above,
whereas a protection of PTCs by BMP-7 synthesized in the
glomeruli12 is at least in physiological circumstances unlikely
according to our data.
The protective effect might be hampered, if BMP-7
expression is significantly reduced, that is, after acute or
prolonged ischemia13,23 or in diabetic nephropathy,14 as
suggested by diverse animal studies. In line with this, in many
conditions of acute ischemia and chronic kidney disease, the
delivery of external BMP-7 appears to be protective and
regenerative: thus, BMP-7 represses proinflammatory genes5
and has a transforming growth factor-b competing anti-
fibrotic activity,24,25 stabilizes the epithelial phenotype
of tubular cells in vivo and in vitro,7,13 and significantly
improves renal function.26
Altogether, the data suggest that BMP-7 plays a physio-
logical role mostly in the distal tubulus. Still, as reported
previously, PTCs might be responsive to BMP-7, but not in
an autocrine or paracrine mode.
MATERIALS AND METHODS
Clinical cases
Samples of six normal human kidneys were obtained immediately
during surgical nephrectomy for neoplastic kidney disease. By visual
control, only tumor-free healthy areas of the kidney were used.
Conventional immunohistochemistry
Tissues samples were fixed with 10% formalin and embedded with
paraffin. Thick tissue sections of 4 mm were used for immunostain-
ing (for pretreatment and antibody dilutions, see Table 1). All
primary antibodies were applied at 4 1C in a moist chamber over
night. Primary antibodies were linked with a streptavidine-
conjugated secondary antibody and labelled with biotin-conjugated
alkaline phosphatase. Staining was performed with a fast red
containing solution.
Negative controls were performed by replacing the primary
antibodies with Tris-buffered saline and with the immunizing
protein.
Immunofluorescence analysis
Tissue samples were fixed with 10% formalin and embedded in
paraffin. Tissue sections (4mm thick) were used for immuno-
localization studies (for pretreatments and antibody dilutions, see
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Figure 5 | Immunolocalization of IDI in normal adult kieney. (a, d)
Immunolocalization of ID1 a: original magnification 20
(bar¼ 100 mm); d: original magnification 40 (bar¼ 50 mm) in normal
adult kidney: positive staining for ID1 was observed in distal tubular
structures, whereas glomeruli and the proximal tubuli remained
unstained. (b, e) Double immunofluorescence for ID1 (red) and
Tamm-Horsfall-protein (THP; green) b: original magnification 20
(bar¼ 50mm); e: original magnification 40 (bar¼ 200mm): again
only a small number of double-positive tubuli is seen. (c, f) Double
immunofluorescence for ID1 (red) and BMP-7 (green) c: original
magnification 8 (bar¼ 200 mm); f: original magnification 40
(bar¼ 50mm): again a higher number of double-positive tubuli
besides tubuli positive only for ID1.
Table 1 | Primary antibodies and enzymatic pretreatments used for immunohistochemical analyses
Species Dilution Digestion Source
BMP-7 (N-19) g 1:100 — Santa Cruz Biotechnologies, Santa Cruz, CA, USA
p-Smads 1/5(8) r 1:100 pt US Biological, Swampscott, MA, USA
Calbindin D28k r 1:2000 — Chemicon, Temecula, CA, USA
THP g 1:2000 — ICN Biomedicals, Aurora, OH, USA
ID1 C-20 r 1:500 — Santa Cruz Biotechnologies, Santa Cruz, CA, USA
BMP, bone morphogenetic protein; ID1, inhibitor of differentiation factor 1; pt, protease XXIV (Sigma, FRG; 0.02 mg/ml in PBS, pH 7.3, 60 min at RT); r/g, rabbit/goat polyclonal;
THP, Tamm–Horsfall protein.
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Table 1). All primary antibodies were applied at 41C in a moist
chamber over night. Primary antibodies were detected using
secondary antibodies labeled either with Alexa-488 or Cy-5
(Dianova, Hamburg, FRG). Nuclear counterstain was performed
with 40,6-diamino-2-phenylindole-2HCl. Seventy percent glycerin
was used as mounting medium.
Double-labelling fluorescence microscopy
For double-labelling immunofluorescence using goat and rabbit
polyclonal antibodies (Table 1), histological sections were pre-
treated with protease (2 mg/ml in Tris-buffered saline (pH 7.3) for
60 min at 371C; Sigma, Taufkirchen, FRG) and incubated with a
mixture of both antibodies with goat primary antibodies used at a
10 times higher concentration than in conventional immuno-
histochemistry. The goat antibodies were detected using Alexa-488-
labelled donkey-anti-goat (Dianova, Hamburg, FRG). For the
detection of the rabbit antibodies sections were first incubated with
biotin-labelled donkey-anti-rabbit antibodies (Dianova) and then
with peroxidase-labelled streptavidin. Subsequently, the tyramide
amplification system (Perkin-Elmer, Boston, USA) was used. Finally,
the signals were detected using Cy5-labelled streptavidin (Dianova).
Nuclear staining was again performed using 406-diamino-2-
phenylindole-2HCl.
The sections were evaluated by a (fluorescence) microscope
(Olympus AX70) and digitally photographed.
Laser scanning confocal microscopy
Confocal scanning microscopy was performed using a Leica TCS
SP-II microscope (Leica, Wetzlar, Germany). For detection, Cy-5 was
used as fluorochrome (Dianova, Hamburg, Germany) as renal tissue
did not show any autofluorescence at the Cy-5 excitation
wavelength.
Isolation of primary human tubular cells
Primary human adult tubular cells were isolated according to a
protocol published by Trifillis et al.27 Briefly, 2 2 cm measuring
tumor-free pieces were taken under sterile conditions from the
cortex of a tumor nephrectomy sample. After removal of the capsule
and the medulla, the cortex was cut into 5 mm pieces, which were
washed in Hank’s balanced salt solution and digested by sterile
collagenase type 1a. The digest was filtered through two cell sieves
with a 100 mash and a 300 mash screen. The cell suspension
was washed twice in Hank’s balanced salt solution and plated at
1.5 million cells on a Petri culture dish and kept in Dulbecco’s
modified Eagle’s medium/F12 containing 5% fetal calf serum, 1%
insulin/transferrin (Sigma), 0.1% hydrocortisone, 1% penicillin/
streptomycin, 1% glutamate, and 4-(2-hydroxyethyl)-1-piperazine-
ethanesulfonic acid. After 4 days, the cells were splitted 1:5.
Cell culture
Immortalized cell lines of PTCs (HK-2) were cultured in keratinocyte
serum-free medium containing 5 ng/ml epidermal growth factor and
50 mg/ml bovine pituitary extract. Primary tubular cells were
cultured in the medium as described above. Before starting the
experiments confluent cells were kept for 24 h under starvation
(without epidermal growth factor/bovine pituitary extract or fetal
calf serum).
RNA isolation from cultured distal tubular cells and intact
renal tissue
RNA was isolated from cultured tubular cells using the RNeasy
minikit (Qiagen, Germany) (with an on-column DNAse digestion
step, according to the manufacturer’s instructions). Briefly, cells
were passed through a Qiashredder (Qiagen, Germany) and the
eluted lysate was mixed 1:1 with 70% ethanol. The lysate was applied
to a minicolumn, and after washing and DNAse digestion, the RNA
was eluted in 30–50 ml of RNAse-free water.
RNA was isolated from normal renal tissue according to a
protocol previously published using the RNeasy minikit (Qiagen,
Germany) (with an on-column DNAse digestion step, according to
the manufacturer’s instructions).28
The quantity and quality of RNA was assessed by ethidium
bromide staining of RNA separated on 1.2% agarose gels.
cDNA synthesis – conventional PCR
First-strand cDNA was synthesized using 2 mg of total RNA, 400 U
Moloney murine leukemia virus Reverse Transcriptase, RNase H
Minus (Promega, Mannheim, FRG), 2 mM deoxynucleoside triphos-
phates (Roth, FRG) and 200 ng random primers (Promega) in a
total volume of 40ml. For conventional PCR, cDNA equivalent to
50 ng total RNA was first denatured (941C, 4 min) and then
amplified in a 35 cycle protocol (941C/30 s–601C/30 s–721C/60 s)
Table 2 | Sequences of primers and probes for quantitative online-PCR experiments
Gene Acc. No. Primers Probe [MgCl2]
GAPDH NM_002046 fw: GAAGGTGAAGGTCGGAGTC CAAGCTTCCCGTTCTCAGCC 5.5
rv: GAAGATGGTGATGGGATTTC
Smad 1 NM_005900 fw: CACAAACATGATGGCGCCT CCCTGCCCTCAGAAATCAACAGAGGAGA 6.5
rv: CATAGTAGACAATAGAGCACCAGTGTTT
Smad 5 NM_005903 fw: ACCAGCCCAACAACACTCCT TTCCCTTATCTCCAAACAGCCCTTATCCCC 4.5
rv: AGCTGAAATGGACTTCCTGGTC
Smad 8 NM_005905 fw: TCCTGGCCAAGTTCCGC CCTCCCTGCACAGTGAGCCACTCA 4.5
rv: AGTGCAGAGCACGGAGGC
BMP-RIA NM_004329 fw: CCTTTATTGGTTCAGCGAACTATTG AAACAGATTCAGATGGTCCGGCAAGTTG 6
rv: TTGCCCATCCATACTTCTCCATA
BMP-RIB D89675 fw: CAAAGGTCTTGCGTTGTAAATGC ACCACCATTGTCCAGAAGACTCAGTCAACA 4.5
rv: CAATATCCGTCTGTGCTGCAAA
BMP-RII NM_001204 fw: CTACCATGGACCATCCTGCTG AGCACTGCGGCTGCTTCGCA 5.5
rv: CGCACATAGCCGTTCTTGATT
BMP-7 M60316 fw: ACGCTTCGACAATGAGACGTT CGGATCAGCGTTTATCAGGTGCTCCA 7
rv: TTCCCTGCCCAAGTGCTC
BMP, bone morphogenetic protein; fw, forward; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PCR, polymerase chain reaction; rv, reverse.
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using SilverStar-DNA-Polymerase (Eurogentec, Belgium). Buffers
and nucleotides were used in standard concentrations and
purchased from Roth (FRG). MgCl2 was added at 1.5 mM. The
following primers were used for amplifying a 500 bp fragment of
BMP-7 cDNA, fw 50-TTC CCC TCC CTA TCC CCA ACT TT-30, and
rv 50-TTT TCC TTT CGC ACA GAC ACC-30.
TAQMAN PCR. TAQMAN PCR was used to detect human
Smads 1, 5, 8, BMP-RIA, -RIB, and RII and BMP-7. The primers
(MWG Biotech, Germany) and TAQMAN probes (Eurogentec,
Belgium) were designed using PRIMER EXPRESS TM software
(Perkin-Elmer). In order to be able to obtain quantifiable results for
all genes, specific standard curves using sequence-specific control
probes were performed in parallel to the analyses. Thus, for each
gene a gene-specific cDNA fragment was amplified by the gene-
specific primers (Table 2) and cloned into pGEM T Easy (Promega)
or pCRII TOPO (Invitrogen, Karlsruhe, FRG). The cloned
amplification product was sequenced for confirmation of correct
cloning. Cloned standard probes were amplified using the Qiagen
amplification kit (Qiagen, FRG), linearized, and used after careful
estimation of the concentration (gel electrophoresis, UV-photo-
metry, and a fluorimetric assay for DNA (Picogreen; Invitrogen,
Karlsruhe, FRG)). For the standard curves, concentrations of 10,
100, 1000, 10 000, 100 000, as well as 1 000 000 molecules per assay
were used (all in triplicates).
For the analyses of the different genes, a separate master-mix was
made up for each of the primer pairs and contained a final
concentration of 200 mM nucleotide triphosphates, 600 nM Roxbuffer,
and 100 nM TAQMAN probe. For all genes the final reaction mix
contained besides cDNA and 1 U polymerase (Eurogentec, Belgium),
forward and reverse primers, the corresponding probes, and MgCl2
at concentrations given in Table 2. All experiments were performed
in triplicates.
The assay for glyceraldehyde-3-phosphate dehydrogenase was
described previously.29
Laser-assisted microdissection and RNA isolation
Frozen tissue specimens from human control kidneys were cut
as a series of 5-mm-thick sections with a clean blade and mounted
on slides coated with a special membrane. To minimize degradation,
slides were fixed with 100% ethanol for 1 min, then 70% ethanol
for 1 min, washed in diethylpyrocarbonate-treated deionized water,
and stained with the hematoxylin, then washed with diethyl-
pyrocarbonate-treated deionized water, and dipped for 1 min in
70, 96, and 100% ethanol. The excess ethanol was removed by
gently tapping the slide on an absorbent surface, air-dried for
about 10 min at room temperature, and stored at 801C before
use. Glomerular and tubular structures (distal and proximal
tubuli) were dissected by focal melting of the membrane with a
UV laser beam. Microdissected fragments were selected and laser
caption microdissection was performed by transferring the
samples into adhesive caps (Molecular Machines & Industries AG,
Switzerland) on RNAse-free conditions as described elsewhere in
detail.30
For RNA isolation from the microdissected tissue, the RNeasy
microkit was used (Qiagen, Hilden, Germany) with lysis buffer
being supplemented with ExpressArt RNA Care N-Carrier (1ml/
100ml buffer). Hundred microliter of lysis buffer was added and
reaction tubes with laser caption microdissection samples were
incubated for about 15 min. Then, total RNA from laser caption
microdissection of glomeruli and tubuli was isolated with spin
columns following the manufacturer’s protocol.
For RNA quality control and for estimates of RNA quantity,
aliquots of the isolated RNA samples were analyzed using the RNA
6000 Pico Assay kit (Agilent Technologies, Bo¨blingen, FRG) in the
Agilent 2100 bioanalyser.
First-strand cDNA was synthesized and quantitative PCR was
performed as described above.
ACKNOWLEDGMENTS
We are grateful for the expert technical help by Stephan Soellner and
Susanne Fickenscher. This work was supported by the DFG (SFB 423,
project Z2).
REFERENCES
1. Simic P, Vukicevic S. Bone morphogenetic proteins in development
and homeostasis of kidney. Cytokine Growth Factor Rev 2005; 16:
299–308.
2. Ozkaynak E, Schnegelsberg PN, Oppermann H. Murine osteogenic
protein (OP-1): high levels of mRNA in kidney. Biochem Biophys Res
Commun 1991; 179: 116–123.
3. Vukicevic S, Basis V, Rogic D et al. Osteogenic protein-1 (bone
morphogenetic protein-7) reduces severity of injury after ischemic
acute renal failure in rat. J Clin Invest 1998; 102: 202–214.
4. Stypmann J, Glaser K, Roth W et al. Dilated cardiomyopathy in mice
deficient for the lysosomal cysteine peptidase cathepsin L. Proc Natl Acad
Sci USA 2002; 99: 6234–6239.
5. Gould SE, Day M, Jones SS et al. BMP-7 regulates chemokine, cytokine,
and hemodynamic gene expression in proximal tubule cells. Kidney Int
2002; 61: 51–60.
6. Leung-Hagesteijn C, Hu MC, Mahendra AS et al. Integrin-linked kinase
mediates bone morphogenetic protein 7-dependent renal epithelial cell
morphogenesis. Mol Cell Biol 2005; 25: 3648–3657.
7. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts TGF-beta1-
induced epithelial-to-mesenchymal transition and reverses chronic renal
injury. Nat Med 2003; 9: 964–968.
8. Zeisberg M, Shah AA, Kalluri R. Bone morphogenic protein-7 induces
mesenchymal to epithelial transition in adult renal fibroblasts and
facilitates regeneration of injured kidney. J Biol Chem 2005; 280:
8094–8100.
9. Sebald W, Nickel J, Zhang JL et al. Molecular recognition in bone
morphogenetic protein (BMP)/receptor interaction. Biol Chem 2004; 385:
697–710.
10. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth
Factors 2004; 22: 233–241.
11. Ryan MJ, Johnson G, Kirk J et al. HK-2: an immortalized proximal tubule
epithelial cell line from normal adult human kidney. Kidney Int 1994; 45:
48–57.
12. Kitten AM, Kreisberg JI, Olson MS. Expression of osteogenic protein-1
mRNA in cultured kidney cells. J Cell Physiol 1999; 181: 410–415.
13. Simon M, Maresh JG, Harris SE et al. Expression of bone morphogenetic
protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol
1999; 276: F382–F389.
14. Wang SN, LaPage J, Hirschberg R. Loss of tubular bone morphogenetic
protein-7 in diabetic nephropathy. J Am Soc Nephrol 2001; 12: 2392–2399.
15. Jena N, Martin-Seisdedos C, McCue P et al. BMP-7 null mutation in mice:
developmental defects in skeleton, kidney and eye. Exp Cell Res 1997;
230: 28–37.
16. Bosukonda D, Shih MS, Sampath KT et al. Characterization of receptors for
osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat
kidneys. Kidney Int 2000; 58: 1902–1911.
17. Denissova NG, Pouponnot C, Long J et al. Transforming growth factor
beta-inducible independent binding of SMAD to the Smad7 promoter.
Proc Natl Acad Sci USA 2000; 97: 6397–6402.
18. Itoh S, Landstro¨m M, Hermansson A et al. Transforming growth factor b1
induces nuclear export of inhibitory Smad7. J Biol Chem 1998; 272:
29195–29201.
19. Yang X, Ji X, Shi X et al. Smad 1 domains interacting with Hoxc-8 induce
osteoblast differentiation. J Biol Chem 2000; 275: 1065–1072.
20. von Gersdorff G, Susztak K, Rezvani F et al. Smad3 and Smad4 mediate
transcriptional activation of the human Smad7 promoter by transforming
growth factor beta. J Biol Chem 2000; 275: 11320–11326.
21. Takase M, Imamura T, Sampath TK et al. Induction of Smad 6 mRNA by
bone morphogenic proteins. Biochem Biophys Res Commun 1998; 244:
26–29.
722 Kidney International (2006) 70, 717–723
o r i g i n a l a r t i c l e P Wetzel et al.: BMP expression in the human kidney
22. Yamada M, Szendro PI, Prokscha A et al. Evidence for a role of Smad 6 in
chick cardiac development. Dev Biol 1999; 215: 48–61.
23. Almanzar MM, Frazier KS, Dube PH et al. Osteogenic protein-1 mRNA
expression is selectively modulated after acute ischemic renal injury.
J Am Soc Nephrol 1998; 9: 1456–1463.
24. Lund RJ, Davies MR, Hruska KA. Bone morphogenetic protein-7:
an anti-fibrotic morphogenetic protein with therapeutic importance
in renal disease. Curr Opin Nephrol Hypertens 2002; 11: 31–36.
25. Morrissey J, Hruska K, Guo G et al. Bone morphogenetic protein-7
improves renal fibrosis and accelerates the return of renal function.
J Am Soc Nephrol 2002; 13(Suppl 1): S14–S21.
26. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis:
the role of bone morphogenic protein-7 and hepatocyte growth factor.
Kidney Int Suppl 2003; 87: S105–S112.
27. Trifillis AL, Regec AL, Trump BF. Isolation, culture and characterization of
human renal tubular cells. J Urol 1985; 133: 324–329.
28. McKenna LA, Gehrsitz A, Soeder S et al. Effective isolation of high quality
total RNA from human adult articular cartilage. Anal Biochem 2000; 286:
80–85.
29. Gehrsitz A, McKenna LA, Soeder S et al. Isolation of RNA from small
human articular cartilage specimens allows quantification of mRNA
expression levels in local articular cartilage defects. J Orthop Res 2001; 19:
478–482.
30. Dimmler A, Haas CS, Cho S et al. Laser capture microdissection and
real-time PCR for analysis of glomerular endothelin-1 gene
expression in mesangiolysis of rat anti-Thy 1.1 and murine Habu
Snake Venom glomerulonephritis. Diagn Mol Pathol 2003; 12:
108–117.
Kidney International (2006) 70, 717–723 723
P Wetzel et al.: BMP expression in the human kidney o r i g i n a l a r t i c l e
